NOT-OD-07-062: Notice of Intent to Publish a Request for Applications (RFA) for the Rare Diseases Clinical Research Consortia

Notice of Intent to Publish a Request for Applications (RFA) for the Rare Diseases Clinical Research Consortia

Notice Number: NOT-OD-07-062

Key Dates
Release Date: April 19, 2007

Issued by
Office of Rare Diseases (ORD) (http://rarediseases.info.nih.gov/)
National Institutes of Health (NIH) (http://www.nih.gov)

The Purpose of this Notice is to indicate the intent to publish an RFA to continue the Rare Diseases Clinical Research Consortia (RDCRC) Program and to alert potential applicants of the objectives of this cooperative agreement program. This RFA will be open to current Consortia as well as to new applicants. It is anticipated that this RFA will be published by December 2007.

The purpose of this cooperative research program is to facilitate clinical research in rare diseases through support for 1) collaborative clinical research in rare diseases, including longitudinal studies of individuals with rare diseases, clinical studies, phase one and two trials, and/or pilot and demonstration projects; 2) training of clinical investigators in rare diseases research; 3) a test bed for distributed clinical data management that incorporates novel approaches and technologies for data management, data mining, and data sharing across rare diseases, data types, and platforms; and 4) access to information related to rare diseases for basic and clinical researchers, academic and practicing physicians, patients, and the lay public. Each RDCRC must include a consortium of clinical investigators, institutions, and relevant organizations, including patient support organizations, for the study of a subgroup of rare diseases. This cooperative program will facilitate identification of biomarkers for disease risk, disease severity/activity, and measures of clinical outcome appropriate for applicability to clinical trials and encourage development of new approaches to diagnosis, prevention, and treatment of rare diseases.

It is anticipated that approximately six awards will be made.

Inquiries

For further information regarding this potential reissue of RFA, please contact (preferably by e-mail):

Rashmi Gopal-Srivastava, Ph.D.
Director, Extramural Research Program
Office of Rare Diseases, National Institutes of Health
6100, Executive Boulevard Room3B-01, MSC 7518
Bethesda, Maryland 20892-7518
Phone: 301-402-4336
E-mail: gopalr@mail.nih.gov

Stephen C. Groft, Pharm. D.
Director, Office of Rare Diseases
National Institutes of Health
6100, Executive Boulevard Room3B-01, MSC 7518
Bethesda, Maryland 20892-7518
Phone: 301-435-6041
E-mail: GroftS2@od.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.